Erin Jamula

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Feasibility of a Multidisciplinary IV Iron Pathway for Women with Iron Deficiency Anemia Undergoing Gynecologic Surgery: The STRONG Pilot Study.

Feasibility of a Multidisciplinary IV Iron Pathway for Women with Iron Deficiency Anemia Undergoing Gynecologic Surgery: The STRONG Pilot Study.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC

Published: March 16, 2026

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey.

Red blood cell transfusion thresholds in acute leukemia: Current practice and physician perspectives from a national survey.

Journal: Transfusion

Published: October 28, 2025

Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.

Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.

Journal: Clinical and investigative medicine. Medecine clinique et experimentale

Published: March 28, 2024

Bleeding self-assessments by patients with immune thrombocytopenia (ITP): An agreement study.

Bleeding self-assessments by patients with immune thrombocytopenia (ITP): An agreement study.

Journal: American journal of hematology

Published: November 28, 2023

Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.

Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.

Journal: Transfusion

Published: September 06, 2023

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.

Journal: American journal of hematology

Published: September 05, 2023

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCE.

Journal: Transfusion

Published: July 27, 2023

A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma.

A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma.

Journal: Transfusion

Published: July 28, 2022

Lessons learned from the CONCOR-1 trial.

Lessons learned from the CONCOR-1 trial.

Journal: Transfusion medicine (Oxford, England)

Published: January 18, 2022

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.

Journal: Nature medicine

Published: January 13, 2022

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.

Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19.

Journal: Nature medicine

Published: November 02, 2021

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia.

Journal: Blood advances

Published: June 25, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026